PRKN and metabolic dysfunction-associated steatotic liver disease: Mitophagy is progressively impaired with the progression of NAFLD, and enhancement in PINK1-Parkin–mediated mitophagy has been shown to ameliorate liver steatosis (29), revealing the importance of effective mitophagy for the restraint of disease.